Key result
Female sex was associated with lower receipt of temporary mechanical circulatory support and higher in-hospital mortality in AMI-CS.
Why the study?
Women with AMI-CS have historically received mechanical circulatory support less often than men and had higher mortality. Whether these sex differences persist in the contemporary era and how vascular and access complications differ by sex across device types was uncertain.
Does female sex affect the receipt of temporary mechanical circulatory support, vascular and access complications, and in-hospital mortality in adults hospitalized with acute myocardial infarction complicated by cardiogenic shock?
Cohort (n=331,905)
Yes
Does female sex affect the receipt of temporary mechanical circulatory support, vascular and access complications, and in-hospital mortality in adults hospitalized with acute myocardial infarction complicated by cardiogenic shock?
Answers are grounded in this paper and cite their sources.
In a contemporary US national cohort of AMI-CS admissions (2016–2023), women remained significantly less likely to receive temporary mechanical circulatory support and experienced higher rates of access-site vascular complications and in-hospital mortality across all device types compared with men.
Aims Women with acute myocardial infarction and cardiogenic shock (AMI-CS) have historically received mechanical circulatory support (MCS) less often than men and have had higher mortality. Whether these differences persist in the contemporary era, and how vascular and access complications differ by sex across device types, is uncertain. Methods and results Using the National Inpatient Sample (2016 to 2023), we identified 66 381 admissions (331 905 weighted) with acute myocardial infarction and a secondary diagnosis of cardiogenic shock, of whom 34.2% were women. MCS was classified as intra-aortic balloon pump, percutaneous left ventricular assist device, or extracorporeal membrane oxygenation. Associations with female sex were estimated using survey-weighted logistic regression; race and hospital region, unavailable in 2023, were adjusted in a 2016 to 2022 sensitivity analysis. After adjustment, women were less likely than men to receive any MCS [odds ratio (OR) 0.77, 95% CI 0.74 to 0.80] and each device. Women had higher in-hospital mortality overall (OR 1.17, 1.13 to 1.22) and among recipients (OR 1.18, 1.11 to 1.26), without significant variation by device (interaction P = 0.74). Women had more acute limb ischaemia (OR 1.76) and blood transfusion (OR 1.27), consistently across device types. In sequential models further adjusted for device and coded complications, the mortality difference persisted (OR 1.22). Conclusion In contemporary practice, women with AMI-CS received less MCS and had higher mortality and more access-site complications than men. The mortality difference persisted after adjustment and should be interpreted cautiously, as residual confounding by unmeasured shock severity cannot be excluded.
No takes yet. Share an insight, caveat, or question.
Polana et al. (2026) conducted a cohort in Acute myocardial infarction complicated by cardiogenic shock (AMI-CS) (n=331,905). Female sex vs. Male sex was evaluated on In-hospital mortality (OR 1.17, 95% CI 1.13 to 1.22, p=<0.001). Female sex was associated with lower receipt of temporary mechanical circulatory support and higher in-hospital mortality in AMI-CS.
Synapse has enriched 10 related papers. Consider them for comparative context: